CompoSecure (NASDAQ:CMPO) versus Medical Cannabis Payment Solutions (OTCMKTS:REFG) Financial Review

CompoSecure (NASDAQ:CMPO) and Medical Cannabis Payment Solutions (OTCMKTS:REFG) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, earnings, valuation and dividends.

Risk and Volatility

CompoSecure has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, Medical Cannabis Payment Solutions has a beta of -0.65, suggesting that its stock price is 165% less volatile than the S&P 500.

Profitability

This table compares CompoSecure and Medical Cannabis Payment Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CompoSecure	-24.53%	-65.50%	26.83%
Medical Cannabis Payment Solutions	N/A	N/A	N/A

Insider and Institutional Ownership

37.6% of CompoSecure shares are owned by institutional investors. 52.1% of CompoSecure shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares CompoSecure and Medical Cannabis Payment Solutions”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CompoSecure	$160.68 million	9.57	-$53.72 million	($2.16)	-5.63
Medical Cannabis Payment Solutions	N/A	N/A	N/A	N/A	N/A

Medical Cannabis Payment Solutions has lower revenue, but higher earnings than CompoSecure.

Analyst Recommendations

This is a summary of current ratings and recommmendations for CompoSecure and Medical Cannabis Payment Solutions, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CompoSecure	0	0	6	0	3.00
Medical Cannabis Payment Solutions	0	0	0	0	0.00

CompoSecure presently has a consensus target price of $25.50, suggesting a potential upside of 109.70%. Given CompoSecure’s stronger consensus rating and higher possible upside, equities research analysts clearly believe CompoSecure is more favorable than Medical Cannabis Payment Solutions.

Summary

CompoSecure beats Medical Cannabis Payment Solutions on 8 of the 10 factors compared between the two stocks.

About CompoSecure

CompoSecure, Inc. manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others. In addition, it offers Payments + Arculus Secure Authenticate, white-labeled cold storage wallet, Payments + Arculus Cold Storage, and Payments + Arculus Authentication + Arculus Cold Storage. The company serves financial institutions, plastic card manufacturers, system integrators, and security specialists. CompoSecure, Inc. was founded in 1910 and is based in Somerset, New Jersey.

About Medical Cannabis Payment Solutions

Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.